mibe Arzneimittel

mibe Arzneimittel

Grünwald, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

mibe GmbH Arzneimittel is a mid-sized, revenue-generating contract development and manufacturing organization (CDMO) and generic drug producer, wholly owned by Dermapharm AG. With over 700 employees at its state-of-the-art facility, it is a key production asset committed to the German manufacturing base. The company has consistently expanded its capabilities over two decades, now offering a broad range of dosage forms including tablets, liquids, sterile products, hormones, and ointments, supported by extensive in-house analytics and logistics.

Broad Generic PortfolioHormonal ContraceptivesConsumer Health (Cosmetics, Dietary Supplements)

Technology Platform

Integrated GMP manufacturing platform for multiple dosage forms (tablets, liquids, sterile products, hormones, ointments) supported by extensive in-house analytical laboratories.

Funding History

1
UndisclosedUndisclosed

Opportunities

Growing demand for EU-based, reliable generic drug manufacturing enhances the value of its 'Made in Germany' production site.
Its role as Dermapharm's central logistics hub creates efficiency and scale advantages.
Expansion of CDMO services for third parties represents a potential growth vector.

Risk Factors

Complete dependency on the strategic and financial health of parent company Dermapharm AG.
Exposure to intense pricing pressure and regulatory hurdles in the generic drug market.
High operational cost base in Germany compared to international competitors.

Competitive Landscape

mibe competes within the crowded European generic manufacturing and CDMO sector against large global players (e.g., Viatris, Teva, STADA) and specialized CDMOs. Its key differentiators are its vertical integration within Dermapharm, its broad in-house technological spectrum, and its strategic location as a centralized logistics hub for the group.